TY - JOUR
T1 - Transcatheter closure of patent ductus arteriosus
T2 - Past, present and future
AU - Baruteau, Alban Elouen
AU - Hascoët, Sébastien
AU - Baruteau, Julien
AU - Boudjemline, Younes
AU - Lambert, Virginie
AU - Angel, Claude Yves
AU - Belli, Emre
AU - Petit, Jérôme
AU - Pass, Robert
PY - 2014/2
Y1 - 2014/2
N2 - Summary This review aims to describe the past history, present techniques and future directions in transcatheter treatment of patent ductus arteriosus (PDA). Transcatheter PDA closure is the standard of care in most cases and PDA closure is indicated in any patient with signs of left ventricular volume overload due to a ductus. In cases of left-to-right PDA with severe pulmonary arterial hypertension, closure may be performed under specific conditions. The management of clinically silent or very tiny PDAs remains highly controversial. Techniques have evolved and the transcatheter approach to PDA closure is now feasible and safe with current devices. Coils and the Amplatzer Duct Occluder are used most frequently for PDA closure worldwide, with a high occlusion rate and few complications. Transcatheter PDA closure in preterm or low-bodyweight infants remains a highly challenging procedure and further device and catheter design development is indicated before transcatheter closure is the treatment of choice in this delicate patient population. The evolution of transcatheter PDA closure from just 40 years ago with 18 F sheaths to device delivery via a 3 F sheath is remarkable and it is anticipated that further improvements will result in better safety and efficacy of transcatheter PDA closure techniques.
AB - Summary This review aims to describe the past history, present techniques and future directions in transcatheter treatment of patent ductus arteriosus (PDA). Transcatheter PDA closure is the standard of care in most cases and PDA closure is indicated in any patient with signs of left ventricular volume overload due to a ductus. In cases of left-to-right PDA with severe pulmonary arterial hypertension, closure may be performed under specific conditions. The management of clinically silent or very tiny PDAs remains highly controversial. Techniques have evolved and the transcatheter approach to PDA closure is now feasible and safe with current devices. Coils and the Amplatzer Duct Occluder are used most frequently for PDA closure worldwide, with a high occlusion rate and few complications. Transcatheter PDA closure in preterm or low-bodyweight infants remains a highly challenging procedure and further device and catheter design development is indicated before transcatheter closure is the treatment of choice in this delicate patient population. The evolution of transcatheter PDA closure from just 40 years ago with 18 F sheaths to device delivery via a 3 F sheath is remarkable and it is anticipated that further improvements will result in better safety and efficacy of transcatheter PDA closure techniques.
KW - Grown-up congenital heart disease
KW - Paediatric cardiology
KW - Patent ductus arteriosus
KW - Percutaneous closure
KW - Pulmonary hypertension
UR - http://www.scopus.com/inward/record.url?scp=84896133896&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84896133896&partnerID=8YFLogxK
U2 - 10.1016/j.acvd.2014.01.008
DO - 10.1016/j.acvd.2014.01.008
M3 - Review article
C2 - 24560920
AN - SCOPUS:84896133896
SN - 1875-2136
VL - 107
SP - 122
EP - 132
JO - Archives of Cardiovascular Diseases
JF - Archives of Cardiovascular Diseases
IS - 2
ER -